The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Mitochondrial alterations in fatty liver diseases
Open accessAbstract
Fatty liver diseases can result from common metabolic diseases, as well as from xenobiotic exposure and excessive alcohol use, all of which have been shown to exert toxic effects on hepatic mitochondrial functionality and dynamics. Invasive or complex methodology limits large-scale investigations of mitochondria in human livers. Nevertheless, abnormal mitochondrial function, such as impaired fatty acid oxidation and oxidative phosphorylation, drives oxidative stress and has been identified as an important feature of human steatohepatitis. On the other hand, hepatic mitochondria can be flexible and adapt to the ambient metabolic condition to prevent triglyceride and lipotoxin accumulation in obesity. Experience from studies on xenobiotics has provided important insights into the regulation of hepatic mitochondria. Increasing awareness of the joint presence of metabolic disease-related (lipotoxic) and alcohol-related liver diseases further highlights the need to better understand their mutual interaction and potentiation in disease progression. Recent clinical studies have assessed the effects of diets or bariatric surgery on hepatic mitochondria, which are also evolving as an interesting therapeutic target in non-alcoholic fatty liver disease. This review summarises the current knowledge on hepatic mitochondria with a focus on fatty liver diseases linked to obesity, type 2 diabetes and xenobiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A., & Nader, F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.021 · Cited by 2,235
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Self-citationBlüher, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa004 · Cited by 1,090
Koliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Self-citationMitochondrial dynamics and mitochondrial quality control
Ni, H.-M., Williams, J. A., & Ding, W.-X. (2015) · Redox Biology · doi:10.1016/j.redox.2014.11.006 · Cited by 931
The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
Houten, S. M., Violante, S., Ventura, F. V., & Wanders, R. J. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105045 · Cited by 920
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Self-citationHarrison, S. A., Bashir, M. R., Guy, C. D., Zhou, R., Moylan, C. A., Frias, J. P., Alkhouri, N., Bansal, M. B., Baum, S., Neuschwander-Tetri, B. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32517-6 · Cited by 802
Cellular and Molecular Mechanisms of Metformin Action
LaMoia, T. E., & Shulman, G. I. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa023 · Cited by 791
Mitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
Sunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Fromenty, B., & Pessayre, D. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00012-6 · Cited by 665
Self-citationKarlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
Begriche, K., Massart, J., Robin, M.-A., Bonnet, F., & Fromenty, B. (2013) · Hepatology · doi:10.1002/hep.26226 · Cited by 628
Self-citationZaharia, O. P., Strassburger, K., Strom, A., Bönhof, G. J., Karusheva, Y., Antoniou, S., Bódis, K., Markgraf, D. F., Burkart, V., Müssig, K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30187-1 · Cited by 600
Self-citationBegriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., & Fromenty, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 555
Self-citationAlterations in Liver ATP Homeostasis in Human Nonalcoholic Steatohepatitis: A Pilot Study
Cortez-Pinto, H., Chatham, J., Chacko, V. P., Arnold, C., Rashid, A., & Diehl, A. M. (1999) · JAMA · doi:10.1001/jama.282.17.1659 · Cited by 487
2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death
Grundlingh, J., Dargan, P. I., El-Zanfaly, M., & Wood, D. M. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0162-6 · Cited by 470
Mitochondrial biogenesis and clearance: a balancing act
Ploumi, C., Daskalaki, I., & Tavernarakis, N. (2017) · The FEBS Journal · doi:10.1111/febs.13820 · Cited by 463
Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion
Chavin, K. D., Yang, S., Lin, H. Z., Chatham, J., Chacko, V. P., Hoek, J. B., Walajtys-Rode, E., Rashid, A., Chen, C.-H., Huang, C.-C., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5692 · Cited by 441
Berson, A., De Beco, V., Lettéron, P., Robin, M. A., Moreau, C., Kahwaji, J. E., Verthier, N., Feldmann, G., Fromenty, B., & Pessayre, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70590-6 · Cited by 405
Self-citationMitochondrial metabolism mediates oxidative stress and inflammation in fatty liver
Satapati, S., Kucejova, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K., Fu, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82204 · Cited by 399
Blood contains circulating cell‐free respiratory competent mitochondria
Al Amir Dache, Z., Otandault, A., Tanos, R., Pastor, B., Meddeb, R., Sanchez, C., Arena, G., Lasorsa, L., Bennett, A., Grange, T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901917rr · Cited by 383
Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369
Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia
Liu, H.-Y., Han, J., Cao, S. Y., Hong, T., Zhuo, D., Shi, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033936 · Cited by 352
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330
Self-citationYamada, T., Murata, D., Adachi, Y., Itoh, K., Kameoka, S., Igarashi, A., Kato, T., Araki, Y., Huganir, R. L., Dawson, T. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.014 · Cited by 290
Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1318 · Cited by 284
Self-citationCentral role of mitochondria in drug-induced liver injury
Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.604086 · Cited by 277
Self-citationBoland, M. L., Laker, R. C., Mather, K., Nawrocki, A., Oldham, S., Boland, B. B., Lewis, H., Conway, J., Naylor, J., Guionaud, S., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0209-6 · Cited by 270
Insulin resistance and insulin sensitizing agents
Mastrototaro, L., & Roden, M. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154892 · Cited by 254
Self-citationLuukkonen, P. K., Dufour, S., Lyu, K., Zhang, X.-M., Hakkarainen, A., Lehtimäki, T. E., Cline, G. W., Petersen, K. F., Shulman, G. I., & Yki-Järvinen, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922344117 · Cited by 249
Moore, M. P., Cunningham, R. P., Meers, G. M., Johnson, S. A., Wheeler, A. A., Ganga, R. R., Spencer, N. M., Pitt, J. B., Diaz‐Arias, A., Swi, A. I. A., et al. (2022) · Hepatology · doi:10.1002/hep.32324 · Cited by 240
Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Magkos, F., Su, X., Bradley, D., Fabbrini, E., Conte, C., Eagon, J. C., Varela, J. E., Brunt, E. M., Patterson, B. W., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.003 · Cited by 224
Toxicant-associated Steatohepatitis
Wahlang, B., Beier, J. I., Clair, H. B., Bellis-Jones, H. J., Falkner, K. C., McClain, C. J., & Cave, M. C. (2013) · Toxicologic Pathology · doi:10.1177/0192623312468517 · Cited by 216
Serviddio, G., Bellanti, F., Tamborra, R., Rollo, T., Capitanio, N., Romano, A. D., Sastre, J., Vendemiale, G., & Altomare, E. (2008) · Gut · doi:10.1136/gut.2007.147496 · Cited by 215
Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M. (2011) · Diabetes Care · doi:10.2337/dc10-1076 · Cited by 212
Self-citationInhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
Kennedy, J. A., Unger, S. A., & Horowitz, J. D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00204-3 · Cited by 209
Abnormal Hepatic Energy Homeostasis in Type 2 Diabetes†
Szendroedi, J., Chmelik, M., Schmid, A. I., Nowotny, P., Brehm, A., Krssak, M., Moser, E., & Roden, M. (2009) · Hepatology · doi:10.1002/hep.23093 · Cited by 204
Self-citationAcute dietary fat intake initiates alterations in energy metabolism and insulin resistance
Hernández, E. Á., Kahl, S., Seelig, A., Begovatz, P., Irmler, M., Kupriyanova, Y., Nowotny, B., Nowotny, P., Herder, C., Barosa, C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89444 · Cited by 194
Self-citationImpaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Fletcher, J. A., Deja, S., Satapati, S., Fu, X., Burgess, S. C., & Browning, J. D. (2019) · JCI Insight · doi:10.1172/jci.insight.127737 · Cited by 194
Feng, J., Wang, X., Ye, X., Ares, I., Lopez-Torres, B., Martínez, M., Martínez-Larrañaga, M.-R., Wang, X., Anadón, A., & Martínez, M.-A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106114 · Cited by 194
Interorgan Metabolic Crosstalk in Human Insulin Resistance
Gancheva, S., Jelenik, T., Álvarez-Hernández, E., & Roden, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00015.2017 · Cited by 192
Self-citationMorris, E. M., Meers, G. M. E., Booth, F. W., Fritsche, K. L., Hardin, C. D., Thyfault, J. P., & Ibdah, J. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00169.2012 · Cited by 186
University of Kansas Medical Center, D. O. P., & Jaeschke, H. (2018) · Journal of Clinical and Translational Research · doi:10.18053/jctres.04.201801.005 · Cited by 183
Zhou, H., Zhu, P., Wang, J., Toan, S., & Ren, J. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0094-1 · Cited by 183
Strakovsky, R. S., Wang, H., Engeseth, N. J., Flaws, J. A., Helferich, W. G., Pan, Y.-X., & Lezmi, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.021 · Cited by 180
Insulin resistance in type 1 diabetes mellitus
Kaul, K., Apostolopoulou, M., & Roden, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.002 · Cited by 175
Self-citationExtracellular vesicles as biomarkers in liver diseases: A clinician's point of view
Thietart, S., & Rautou, P.-E. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.014 · Cited by 174
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance
Lyu, K., Zhang, Y., Zhang, D., Kahn, M., ter Horst, K. W., Rodrigues, M. R. S., Gaspar, R. C., Hirabara, S. M., Luukkonen, P. K., Lee, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.001 · Cited by 170
Nadanaciva, S., Dykens, J. A., Bernal, A., Capaldi, R. A., & Will, Y. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.06.003 · Cited by 166
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
Self-citationXian, H., & Liou, Y.-C. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00657-z · Cited by 164
Hao, L., Zhong, W., Dong, H., Guo, W., Sun, X., Zhang, W., Yue, R., Li, T., Griffiths, A., Ahmadi, A. R., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321548 · Cited by 161
Xu, J., Lai, K. K. Y., Verlinsky, A., Lugea, A., French, S. W., Cooper, M. P., Ji, C., & Tsukamoto, H. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.034 · Cited by 159
Metabolic liver disease in diabetes – From mechanisms to clinical trials
Dewidar, B., Kahl, S., Pafili, K., & Roden, M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154299 · Cited by 158
Self-citationBarbier‐Torres, L., Fortner, K. A., Iruzubieta, P., Delgado, T. C., Giddings, E. L., Chen, Y., Champagne, D., Fernández‐Ramos, D., Mestre, D., Gómez‐Santos, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16991-2 · Cited by 157
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
Jelenik, T., Kaul, K., Séquaris, G., Flögel, U., Phielix, E., Kotzka, J., Knebel, B., Fahlbusch, P., Hörbelt, T., Lehr, S., et al. (2017) · Diabetes · doi:10.2337/db16-1147 · Cited by 154
Self-citationAre Lifestyle Therapies Effective for NAFLD Treatment?
El-Agroudy, N. N., Kurzbach, A., Rodionov, R. N., O’Sullivan, J., Roden, M., Birkenfeld, A. L., & Pesta, D. H. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.07.013 · Cited by 152
Self-citationDemeilliers, C., Maisonneuve, C., Grodet, A., Mansouri, A., Nguyen, R. Q., Tinel, M., Lettéron, P., Degott, C., Feldmann, G., Pessayre, D., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35952 · Cited by 149
Self-citationRole of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
INSERM, U., & Fromenty, B. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.006 · Cited by 147
Self-citationMiele, L., Grieco, A., Armuzzi, A., Candelli, M., Forgione, A., Gasbarrini, A., & Gasbarrini, A. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07725.x · Cited by 146
Schirrmacher, V. (2020) · Biomedicines · doi:10.3390/biomedicines8110526 · Cited by 143
Ooi, G. J., Meikle, P. J., Huynh, K., Earnest, A., Roberts, S. K., Kemp, W., Parker, B. L., Brown, W., Burton, P., & Watt, M. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.013 · Cited by 137
Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
Galicia‐Moreno, M., Lucano‐Landeros, S., Monroy-Ramírez, H. C., Silva-Gómez, J. A., Gutiérrez‐Cuevas, J., Santos, A., & Armendáriz‐Borunda, J. (2020) · Antioxidants · doi:10.3390/antiox9100980 · Cited by 135
Drug-induced fatty liver disease: An overview of pathogenesis and management
Satapathy, S. K., Kuwajima, V. K., Nadelson, J., Atiq, O., & Sanyal, A. J. (2015) · Annals of Hepatology · doi:10.5604/16652681.1171749 · Cited by 131
Cano, R., Pérez, J., Dávila, L., Ortega, Á., Gómez, Y., Valero-Cedeño, N., Parra, H., Manzano, A., Véliz-Castro, T. I., Albornoz, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094807 · Cited by 131
Longo, M., Meroni, M., Paolini, E., Erconi, V., Carli, F., Fortunato, F., Ronchi, D., Piciotti, R., Sabatini, S., Macchi, C., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.11.007 · Cited by 129
Serviddio, G., Giudetti, A. M., Bellanti, F., Priore, P., Rollo, T., Tamborra, R., Siculella, L., Vendemiale, G., Altomare, E., & Gnoni, G. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024084 · Cited by 128
Zebrafish: An emerging model system to study liver diseases and related drug discovery
Katoch, S., & Patial, V. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4031 · Cited by 128
Hyötyläinen, T., Jerby‐Arnon, L., Petäjä, E. M., Mattila, I. M., Jäntti, S. E., Auvinen, P., Gastaldelli, A., Yki‐Järvinen, H., Ruppin, E., & Orešič, M. (2016) · Nature Communications · doi:10.1038/ncomms9994 · Cited by 126
Mechanistic review of drug-induced steatohepatitis
Schumacher, J. D., & Guo, G. L. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.08.022 · Cited by 124
Longo, M., Meroni, M., Paolini, E., Macchi, C., & Dongiovanni, P. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154708 · Cited by 123
Degoul, F., Sutton, A., Mansouri, A., Cepanec, C., Valla, D. C., Pessayre, D., Fromenty, B., Degott, C., & Beaugrand, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.24051 · Cited by 118
Self-citationCrescenzo, R., Bianco, F., Falcone, I., Coppola, P., Liverini, G., & Iossa, S. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0356-y · Cited by 118
Diagnosis and management of secondary causes of steatohepatitis
Liebe, R., Esposito, I., Bock, H. H., Dahl, S. V., Stindt, J., Baumann, U., Luedde, T., & Keitel, V. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.045 · Cited by 118
Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver
Massart, J., Begriche, K., Hartman, J. H., & Fromenty, B. (2022) · Cells · doi:10.3390/cells11020288 · Cited by 112
Self-citationde la Rosa, L. C., García‐Ruiz, C., Vallejo, C., Baulies, A., Núñez, S., Monte, M. J., Marín, J. J. G., Baila-Rueda, L., Cenarro, A., Civeira, F., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.028 · Cited by 111
Goedeke, L., & Shulman, G. I. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101178 · Cited by 109
Stevanović, J., Beleza, J., Coxito, P. M., Ascensão, A. A. M. R., & Magalhães, J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.015 · Cited by 108
Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease
Shami, G. J., Cheng, D., Verhaegh, P. L. M., Koek, G. H., Wisse, E., & Braet, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-82884-z · Cited by 105
Misu, H., Takamura, T., Matsuzawa, N., Shimizu, A., Ota, T., Sakurai, M., Ando, H., Arai, K., Yamashita, T., Honda, M., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0489-8 · Cited by 102
Serviddio, G., Bellanti, F., Giudetti, A. M., Gnoni, G. V., Capitanio, N., Tamborra, R., Romano, A. D., Quinto, M., Blonda, M., Vendemiale, G., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.004 · Cited by 101
Wang, C., & Wei, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155266 · Cited by 99
Thyroid Hormone Analogues: An Update
Zucchi, R. (2020) · Thyroid · doi:10.1089/thy.2020.0071 · Cited by 98
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Åberg, F. O., & Färkkilä, M. A. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1701443 · Cited by 94
Petersen, K. F., Befroy, D. E., Dufour, S., Rothman, D. L., & Shulman, G. I. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.005 · Cited by 93
Mitochondrial dysfunction in nonalcoholic steatohepatitis
Serviddio, G., Bellanti, F., Vendemiale, G., & Altomare, E. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.11 · Cited by 91
Lü, H., Cui, W., & Klaassen, C. D. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.07.019 · Cited by 90
Cahill, A., Stabley, G. J., Wang, X., & Hoek, J. B. (1999) · Hepatology · doi:10.1002/hep.510300434 · Cited by 85
Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α
Ramírez-Tortosa, M. C., Ramírez-Tortosa, C. L., Mesa, M. D., Granados-Principal, S. M., Gil, Á., & Quiles, J. L. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.015 · Cited by 82
Dynamic changes of muscle insulin sensitivity after metabolic surgery
Gancheva, S., Ouni, M., Jeleník, T., Koliaki, C. C., Szendroedi, J., Toledo, F. G. S., Markgraf, D. F., Pesta, D. H., Mastrototaro, L., Filippo, E. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12081-0 · Cited by 81
Self-citationVerbeek, J., Lannoo, M., Pirinen, E., Ryu, D., Spincemaille, P., Elst, I. V., Windmolders, P., Thevissen, K., Cammue, B. P. A., van Pelt, J. F., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-306748 · Cited by 79
Zhang, P., Qiang, X., Zhang, M., Ma, D., Zhao, Z., Zhou, C., Liu, X., Li, R., Chen, H., & Zhang, Y. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219832 · Cited by 78
Kupriyanova, Y., Zaharia, O., Bobrov, P., Karusheva, Y., Burkart, V., Szendroedi, J., Hwang, J., Roden, M., Roden, M., Al‐Hasani, H., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.030 · Cited by 78
Self-citationLi, S., Li, X., Chen, F., Liu, M., Ning, L., Yan, Y.-F., Zhang, S., Huang, S., & Tu, C. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108888 · Cited by 77
Mitochondria and Redox Signaling in Steatohepatitis
Morris, E. M., Rector, R. S., Thyfault, J. P., & Ibdah, J. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3795 · Cited by 74
Zaharia, O., Straßburger, K., Knebel, B., Kupriyanova, Y., Karusheva, Y., Wolkersdorfer, M. F., Bódis, K. B., Markgraf, D. F., Burkart, V., Hwang, J., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0329 · Cited by 74
Self-citationUncoupling protein-2 and non-alcoholic fatty liver disease
Baffy, G. (2005) · Frontiers in bioscience · doi:10.2741/1683 · Cited by 73
Brouwers, B., Schrauwen‐Hinderling, V. B., Jeleník, T., Gemmink, A., Sparks, L. M., Havekes, B., Bruls, Y. M. H., Dahlmans, D., Roden, M., Hesselink, M. K. C., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2017 · Cited by 73
Self-citationLiver adapts mitochondrial function to insulin resistant and diabetic states in mice
Frankó, A., von Kleist-Retzow, J., Neschen, S., Wu, M., Schommers, P., Böse, M., Kunze, A., Hartmann, U., Sánchez-Lasheras, C., STOEHR, O., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.020 · Cited by 70
H2O2 release from the very long chain acyl-CoA dehydrogenase
Kakimoto, P. A., Tamaki, F. K., Cardoso, A. R., Marana, S. R., & Kowaltowski, A. J. (2015) · Redox Biology · doi:10.1016/j.redox.2015.02.003 · Cited by 67
Alteration of mitochondrial DNA homeostasis in drug-induced liver injury
Fromenty, B. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110916 · Cited by 67
Self-citationLiver Pyruvate Kinase Promotes NAFLD/NASH in Both Mice and Humans in a Sex-Specific Manner
Krishnan, K. C., Floyd, R. R., Sabir, S., Jayasekera, D. W., León‐Mimila, P., Jones, A. E., Cortez, A. A., Shravah, V., Péterfy, M., Stiles, L., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.09.004 · Cited by 66
Everitt, H., Hu, M., Ajmo, J. M., Rogers, C. Q., Liang, X., Zhang, R., Yin, H., Choi, A., Bennett, E. S., & You, M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00309.2012 · Cited by 64
Obese zebrafish: A small fish for a major human health condition
Faillaci, F., Milosa, F., Critelli, R. M., Turola, E., Schepis, F., & Villa, E. (2018) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12042 · Cited by 64
Lammert, C., Imler, T., Teal, E., & Chalasani, N. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.013 · Cited by 62
Bucher, S., Tête, A., Podechard, N., Liamin, M., Guillou, D. L., Chevanne, M., Coulouarn, C., Imran, M., Gallais, I., Fernier, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24403-1 · Cited by 61
Self-citationGancheva, S., Kahl, S., Pesta, D., Mastrototaro, L., Dewidar, B., Strassburger, K., Sabah, E., Esposito, I., Weiß, J., Sarabhai, T., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1758 · Cited by 60
Self-citationMitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet
Romestaing, C., Piquet, M., Letexier, D., Rey, B., Mourier, A., Servais, S., Belouze, M., Rouleau, V., Dautresme, M., Ollivier‐Hourmand, I., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00407.2007 · Cited by 59
Zamani‐Garmsiri, F., Hashemnia, S. M. R., Shabani, M., Bagherieh, M., Emamgholipour, S., & Meshkani, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108505 · Cited by 59
Sensing the Stress: A Role for the UPRmt and UPRam in the Quality Control of Mitochondria
Callegari, S., & Dennerlein, S. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00031 · Cited by 58
Allard, J., Bucher, S., Massart, J., Ferron, P., Guillou, D. L., Loyant, R., Daniel, Y., Launay, Y., Buron, N., Begriche, K., et al. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09537-1 · Cited by 58
Self-citationSpaniol, M. M., Kaufmann, P., Beier, K., Wuethrich, J., Török, M., Scharnagl, H., März, W., & Krähenbühl, S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200200-jlr200 · Cited by 57
Fouqueray, P., Bolze, S., Dubourg, J., Hallakou‐Bozec, S., Theurey, P., Grouin, J., Chevalier, C., Dagorn, P. G., Moller, D. E., & Cusi, K. J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100474 · Cited by 57
Role of xenobiotics in the induction and progression of fatty liver disease
Klaunig, J. E., Li, X., & Wang, Z. (2018) · Toxicology Research · doi:10.1039/c7tx00326a · Cited by 55
Bucher, S., Guillou, D. L., Allard, J., Pinon, G., Begriche, K., Tête, A., Sergent, O., Lagadic‐Gossmann, D., & Fromenty, B. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4396403 · Cited by 55
Self-citationMolecular Machinery and Pathophysiology of Mitochondrial Dynamics
Chiu, Y., Lin, S., Kuo, C.-H., & Li, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743892 · Cited by 54
Takeichi, Y., Miyazawa, T., Sakamoto, S., Hanada, Y., Wang, L., Gotoh, K., Uchida, K., Katsuhara, S., Sakamoto, R., Ishihara, T., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05488-2 · Cited by 52
Rana, P., Aleo, M. D., Wen, X., & Kogut, S. J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.028 · Cited by 51
Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis
Fromenty, B. (2019) · Liver Research · doi:10.1016/j.livres.2019.06.001 · Cited by 49
Self-citationXenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
Massart, J., Begriche, K., Corlu, A., & Fromenty, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031062 · Cited by 48
Self-citationYamada, T., Murata, D., Kleiner, D. E., Anders, R. A., Rosenberg, A. Z., Kaplan, J., Hamilton, J. P., Aghajan, M., Levi, M., Wang, N., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103996 · Cited by 47
Pedersen, J. S., Rygg, M. O., Chrøis, K. M., Sustarsic, E. G., Gerhart‐Hines, Z., Albrechtsen, N. J. W., Serizawa, R., Kristiansen, V. B., Basse, A. L., Boilesen, A. E. B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30629-5 · Cited by 45
Poussin, C., Ibberson, M. R., Hall, D., Ding, J., Soto, J. E., Abel, E. D., & Thorens, B. (2011) · Diabetes · doi:10.2337/db11-0338 · Cited by 44
Regev, A., Palmer, M., Avigan, M., Dimick‐Santos, L., Treem, W. R., MARCINAK, J. F., Seekins, D. W., Krishna, G., Anania, F. A., Freston, J. W., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15153 · Cited by 42
Barbier‐Torres, L., Murray, B., Yang, J. W., Wang, J., Matsuda, M., Robinson, A., Binek, A., Fan, W., Fernández‐Ramos, D., Lopitz‐Otsoa, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28201-2 · Cited by 41
Chen, Y., Lin, Y., Han, P., Jiang, S., Che, L., He, C., Lin, Y., & Lin, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14388 · Cited by 40
The role of mitochondria in the pathophysiology and treatment of common metabolic diseases in humans
Georgiev, A., Granata, C., & Roden, M. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00035.2022 · Cited by 38
Self-citationJi, C., Dai, Y., Jiang, W., Liu, J., Hou, M., Wang, J., Burén, J., & Li, X. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.06.010 · Cited by 37
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Mehta, R., Jeiran, K., Koenig, A. B., Otgonsuren, M., Goodman, Z. D., Baranova, A. V., & Younossi, Z. M. (2016) · BMC Medical Genetics · doi:10.1186/s12881-016-0324-0 · Cited by 36
Mitochondrial Dynamics in Drug-Induced Liver Injury
Ramachandran, A., Umbaugh, D. S., & Jaeschke, H. (2021) · Livers · doi:10.3390/livers1030010 · Cited by 36
Lund, M. T., Kristensen, M., Hansen, M., Tveskov, L., Floyd, A. K., Støckel, M., Vainer, B., Poulsen, S. S., Helge, J. W., Prats, C., et al. (2016) · The Journal of Physiology · doi:10.1113/jp272105 · Cited by 35
Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance
Sarabhai, T., KAHL, S., Szendroedi, J., Markgraf, D. F., Zaharia, O., Barosa, C., Herder, C., Wickrath, F., Bobrov, P., Hwang, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.134520 · Cited by 34
Self-citationApostolopoulou, M., Gordillo, R., Gancheva, S., Straßburger, K., Herder, C., Esposito, I., Schlensak, M., Scherer, P. E., & Roden, M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001860 · Cited by 34
Self-citationLee, B., Jung, E., Yoo, J., Kim, S. G., Lee, C., Kim, Y. S., Jeong, S. W., Jang, J. Y., Lee, S. H., Kim, H. S., et al. (2020) · Liver International · doi:10.1111/liv.14434 · Cited by 32
Wang, W., Bai, M., Jiang, T., Cui, L., Li, P., Zhou, H., Wang, Z., Li, L., & Jiang, H. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.007 · Cited by 31
Effect of Roux-en-Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity
Sacks, J., Mulya, A., Fealy, C. E., Huang, H., Mosinski, J. D., Pagadala, M. R., Shimizu, H., Batayyah, E., Schauer, P. R., Brethauer, S. A., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13600 · Cited by 28
Afolabi, P. R., Scorletti, E., Smith, D. E., Almehmadi, A., Calder, P. C., & Byrne, C. D. (2018) · Journal of Breath Research · doi:10.1088/1752-7163/aacf12 · Cited by 26
Imran, M., Chalmel, F., Sergent, O., Evrard, B., Mentec, H. L., Legrand, A., Dupont, A., Bescher, M., Bucher, S., Fromenty, B., et al. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09706-4 · Cited by 18
Self-citationInvolvement of fatty acid metabolism in the hepatotoxicity induced by divalproex sodium
Wang, W., Lin, R., Zhang, J., Mao, Y., Bu, X., Ji, Q., Zhai, X., Lin, Q., Yang, L., & Zhang, K. M. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112444477 · Cited by 17
Bouvet, R., Cauchois, A., Baert, A., Fromenty, B., Morel, I., Turlin, B., & Gicquel, T. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110258 · Cited by 14
Self-citationDepdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway
Xu, L., Zhang, X., Yue, X., Ma, J., Yang, C., Zhang, X., Hou, G., Dong, X. C., Sun, Z., Xiong, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03980-6 · Cited by 14
In vitro and in vivo assays for mitochondrial fission and fusion
Hoppins, S. C., Lackner, L. L., Lee, J. E., & Mears, J. A. (2019) · Methods in cell biology · doi:10.1016/bs.mcb.2019.11.010 · Cited by 13
Cited by
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,172
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 800
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
Self-citationIntegrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms
Steinberg, G. R., Valvano, C. M., De Nardo, W., & Watt, M. J. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.02.033 · Cited by 240
Metadata
- Authors
- Fromenty, B., & Roden, M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 78
- Issue
- 2
- Pages
- 415-429
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4302773440
- Cited by
- 424
- References
- 148
- FWCI
- 47.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.